Skip to main content
IMAX logo

IMAX · Imax Corp

Track IMAX — free
$52.09 +0.74 (+1.44%) At close · Sep 11
Market Cap
$2.82B
Shares
54.84M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$52.09 Open$51.71 Day$50.95–52.42 52W close$31.09–54.79 Avg vol 30d1.1M Short int6.8M · 12.3% float · 6.3d Short vol43% Last earningsJul 23, 2026 DataJan 2020–Sep 2026 Filing10-Q · Jul 23

Up next

Next earnings call
Oct 19, 2026 Est · unconfirmed · in 5 wks
filed Jul 23, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$416.08M
Trailing 12 months
Net income (TTM)
$40.92M
Trailing 12 months
Revenue growth YoY
+12.2%
Year over year
Operating margin
20.2%
Trailing 12 months
P / E (TTM)
70.3
Trailing earnings · reciprocal yield 1.4%
FCF yield
4.5%
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+2.6%
Year over year · more shares
Price change (1Y)
+65.4%
Trailing year
Short interest
12.3%
Latest settlement · 6.3 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Strong Sentiment Bullish Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 15.8 · calm Equity put/call 0.60
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +30%
above
Price vs 50-day avg +10%
above
RSI (14) 56
neutral
MACD trend Negative
52-week position 89%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −2%
trailing
6-month return +42%
trailing
YTD return +41%
this year
Relative strength +24%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $47 › 200d $40 — 50d above 200d
Institutional flow Accumulating
+0% holders QoQ · +44 funds added
Insider flow Distributing
Net -$5.1M over 90 days · 100% sells
Short interest Falling
12.32% of float · ▼ -6.9% MoM · 6.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
259 holders — near 3-yr high, broad support
Squeeze score 71
high risk · 0–100
Fundamentals
Excellent
Revenue growth +16%
Y/Y
Gross margin 60%
expanding
EPS growth +31%
Y/Y
Free cash flow $118.9M
Valuation P/E 70.3
rich
Buyback $237.0M
remaining
Balance sheet $187.2M
net cash
Quant / Vol
risk profile
Moderate
Volatility 43%
annualized · 1-yr
Max drawdown −23%
past year
ATR 3.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Apr 30, 2026
Global box office · full year 2026 Initiated $1.4B

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+30% Bullish
Price vs 50-day avg
+10% Bullish
RSI (14)
56 Neutral
MACD trend
Negative Bearish
52-week position
89% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $47 › 200d $40 — 50d above 200d
Institutional flow Accumulating
+0% holders QoQ · +44 funds added
Insider flow Distributing
Net -$5.1M over 90 days · 100% sells
Short interest Falling
12.32% of float · ▼ -6.9% MoM · 6.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
259 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $31 Now $52 · 89% Range high $55
vs 200-day avg +30% vs 50-day avg +10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Entertainment — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IMAX
Imax Corp
this stock
$2.82B +40.9% +16.5% 70.3 12.3%
NFLX
Netflix Inc
$316.50B -17.4% +15.9% 23.9 2.2%
DIS
Walt Disney Co
$183.98B -6.3% +3.4% 22.0 1.2%
WBD
Warner Bros. Discovery, Inc.
$70.31B -2.7% +53.5% 2.7%
LYV
Live Nation Entertainment, Inc.
$40.08B +19.4% +8.8% 10.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
259
% held
95.3%
Net QoQ
+1.6M sh
Top holder
Orbis Allan Gray Ltd
Held Float
View
Held by Funds
Fund positions
236
View
Short & Settlement
Short Interest Falling
Shares short
6.8M
Days to cover
6.3d
Change
-497.9K sh
View
Short Volume
Short vol %
43%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
218.6K
Value
$10.6M
As of
Aug 10, 2026
View
Off-Exchange
Off-exchange %
44.7%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$5.1M
Buyers / Sellers
0 / 6
Buyers Sellers
View
Congressional Trades Sell
Member
Earl Blumenauer
Amount
$1.0K–$15.0K
Traded
Jun 17, 2022
View
Financials
Financials
Revenue (FY)
$410.2M
Net income (FY)
$34.9M
EPS diluted
$0.63
View
Buybacks
Authorized
$500.0M
Remaining
$237.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 21, 2026
This year
12
View
Proposed Sales
Value
$1.6M
Shares
30.0K
Filed
Aug 25, 2026
View
Earnings & Events
Earnings Calls
Last call
Jul 23, 2026
View

Performance

5D 20D 120D MTD YTD
IMAX +0.3% -2.2% +42.0% +1.7% +40.9%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY +1.5% -0.5% +24.1% +2.1% +28.9%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
$500.00M
Spent (derived)
$263.00M
Remaining
$237.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 921582 CUSIP 45245E109 13F (30d) 116 filings 116 filers Visit website Investor relations